For many people with inflammatory bowel disease, remission brings major relief. Diarrhoea, abdominal pain, bleeding and exhaustion may ease. Blood tests may improve. Endoscopy may show a healed bowel lining.
Yet another problem can remain.
Some people with Crohn’s disease or ulcerative colitis find that foods they once ate without difficulty now bring bloating, cramps, urgent bowel movements or changes in stool frequency. Dairy and wheat-based foods are often named. The symptoms can persist even when there is no clear evidence of active inflammation.
New research published in Gastroenterology may help explain why. The study suggests that intestinal inflammation can reshape the gut microbiome and alter immune responses to food. These changes may continue after IBD enters remission, leaving some people more susceptible to food-related symptoms.
The findings do not mean that everyone with IBD has a food allergy. They do not show that gluten or dairy must be avoided. They do, however, offer a biological explanation for an experience many patients have reported for years.
IBD is an umbrella term for chronic inflammatory conditions affecting the digestive tract. The two main types are Crohn’s disease and ulcerative colitis. Crohn’s disease can affect any part of the gastrointestinal tract, while ulcerative colitis affects the colon and rectum.
There is no cure at present. Treatment focuses on controlling inflammation, preventing complications and maintaining remission. Medicines may include anti-inflammatory drugs, immune-modifying treatments and advanced biologic therapies. Some patients need surgery.
Food is not believed to cause IBD. Still, diet often affects symptoms. During active disease, people may struggle with certain foods because the bowel is inflamed, narrowed or poorly able to absorb nutrients. Even in remission, many continue to identify dietary triggers.
High-fat meals, spicy foods, alcohol, caffeine, dairy products and high-fibre foods are frequently reported. Wheat and foods containing gluten are also commonly avoided. These foods do not affect every patient in the same way. A meal that causes severe discomfort for one person may be harmless for another.
The uncertainty can lead to highly restrictive diets. That creates its own risks. People with IBD may already be vulnerable to malnutrition, weight loss, anaemia, low vitamin D, calcium deficiency and reduced muscle mass. Removing several food groups without professional guidance can make nutritional problems worse.
The new study examined whether gut inflammation could create a longer-term tendency towards adverse food reactions. Researchers began with two mouse models of intestinal inflammation. They found that inflamed animals became more likely to develop immune responses to food components, including proteins associated with gluten and dairy.
The response involved immunoglobulin E, or IgE. This type of antibody is widely associated with allergy. IgE can activate mast cells, immune cells that are present in the digestive tract and other tissues. Mast cells release substances that can influence gut movement, pain signalling, fluid secretion and inflammation.
The researchers observed that the immune response in the mouse models was largely localised to the gut. That is a significant detail. A typical food allergy can cause widespread symptoms, including hives, swelling, wheezing, vomiting and, in severe cases, anaphylaxis. The reactions described in this research were different. They appeared to be concentrated in the digestive system.
This may help explain why some people with IBD experience genuine, repeatable symptoms after eating particular foods without having the classic signs of an immediate food allergy. It also means that standard allergy tests may not provide all the answers.
The study then turned to the microbiome. The gut microbiome is the huge and complex community of microorganisms that live in the digestive tract. It includes bacteria, viruses, fungi and other microbes. These organisms help digest food, produce important compounds, support the intestinal barrier and communicate with the immune system.
IBD is already known to be associated with changes in the microbiome. During inflammation, the balance of gut bacteria can shift. Some beneficial bacteria may decrease, while other organisms become more common. These changes can continue even when a person’s symptoms have improved and their bowel appears healed on endoscopy.
In the new research, intestinal inflammation reduced bacteria that normally help break down certain food components. This included microbial activity involved in processing compounds from gluten and dairy products. When these helpful functions decline, food may be broken down differently.
That altered processing could matter. Instead of being handled quietly by the gut, food components or their by-products may become more likely to stimulate local immune activity. The result could be pain, bloating, loose stools or a feeling of intolerance after eating.
To explore this possibility further, researchers transferred gut microbiota from inflamed mice into healthy mice. The healthy recipients became more vulnerable to adverse food reactions. This experiment cannot recreate the full complexity of human IBD. It does, however, suggest that microbiome changes may have an active role in food sensitivity rather than merely reflecting the presence of inflammation.
The human section of the study included 148 adults aged 18 to 75. Participants included people with Crohn’s disease, ulcerative colitis and individuals without IBD. Researchers found similar microbiome changes among people with IBD who reported adverse reactions to certain foods.
That is a meaningful observation, although it is not final proof. Human diets are complicated. Medications, disease severity, surgery, stress, sleep and previous antibiotic use can all affect the microbiome. Food avoidance itself can also alter gut bacteria. A person who stops eating dairy or wheat may gradually develop a different microbial profile from someone who continues to eat those foods.
For this reason, the findings should be viewed as a strong lead rather than a clinical verdict. More large-scale studies are needed. Scientists will need to examine whether these microbial changes predict symptoms, whether they persist over time and whether restoring specific bacterial functions can improve food tolerance.
Still, the research gives a more coherent explanation for a common concern in IBD care. A person can be in clinical remission, have low inflammatory markers and have no visible ulcers on endoscopy, yet continue to feel unwell after certain meals.
These symptoms should not be automatically dismissed. They may not always indicate a disease flare. They may also not be explained by anxiety, poor dietary choices or an imagined sensitivity. The microbiome and local immune system may be part of the picture.
At the same time, food symptoms should be assessed carefully. Active inflammation must be excluded. Other conditions can overlap with IBD or resemble a flare. These include lactose intolerance, coeliac disease, bile acid diarrhoea, small intestinal bacterial overgrowth, infection and irritable bowel syndrome.
A gastroenterologist may use blood tests, stool tests, imaging, endoscopy or other investigations to assess disease activity and rule out complications. A dietitian with IBD expertise can help identify patterns while protecting nutritional intake.
For patients, keeping a food-and-symptom diary may be useful. It can record what was eaten, how much was eaten, the timing of symptoms, stool changes, medication use, stress levels and sleep. Isolated episodes are common. A repeated pattern is more informative.
If a food appears to be a consistent trigger, a supervised elimination and reintroduction approach may be appropriate. This is generally preferable to permanently cutting out multiple food groups. The goal is to identify the smallest necessary restriction, not to create a needlessly narrow diet.
The research also points towards future treatments. If lost microbial functions contribute to food-related symptoms, therapies might eventually be designed to restore them. Possible approaches could include targeted probiotics, prebiotics, enzyme-based treatments, specialised dietary strategies or other microbiome-focused therapies.
These options are still experimental. There is no proven treatment that can reset the microbiome and reliably remove food sensitivities in IBD. Commercial probiotics are not interchangeable, and many have not been adequately studied for this purpose. Patients should discuss supplements and major diet changes with their clinical team.
The implications may stretch beyond IBD. Food sensitivities sometimes appear after gastrointestinal infections or antibiotic treatment, both of which can disrupt gut microbes. People with post-infectious irritable bowel syndrome may also develop new digestive reactions to familiar foods. Whether the same mechanism is involved remains unclear, although the idea is plausible.
For now, the central message is straightforward. IBD remission does not always mean that the gut has returned fully to its earlier state. Inflammation may leave behind changes in gut bacteria and immune signalling. Those changes could affect how food is processed and perceived by the digestive system.
The study offers validation for people whose food-related symptoms have continued despite apparently successful IBD treatment. It also reinforces the need for personalised care. A trigger food list cannot be applied universally. The right diet is one that controls symptoms where possible, supports adequate nutrition and remains realistic enough to sustain.
The post Why New Food Sensitivities Can Develop During IBD Remission, Study Explains first appeared on PP Health Malaysia (PPHM) | 10POINTS Evidence-Based Health News.
